Louise Pelletier1, Siobhan O'Donnell1, Louise McRae1, Jean Grenier2,3. 1. Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario, Canada. 2. Institut de recherche de l'Hôpital Montfort (IRHM), C.T. Lamont Primary Health Care Research Centre, Ottawa, Ontario, Canada. 3. Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Abstract
INTRODUCTION: Although generalized anxiety disorder (GAD) is common and disabling, there are few Canadian studies on this mental illness. We compared the characteristics, health status, health services use and health care needs of Canadians with GAD to those with depression. METHODS: Data are from the 2012 Canadian Community Health Survey-Mental Health, which surveyed a nationally representative sample of Canadians aged 15 years and older (n = 23 709; response rate of 68.9%). The respondents we studied had selfreported symptoms compatible with GAD and/or major depressive episode (MDE) in the preceding 12 months (n = 1598). Estimates were weighted to represent the Canadian household population. We performed descriptive and multinomial multivariate logistic regression analyses. RESULTS: In 2012, an estimated 700 000 (2.5%) Canadians aged 15 years and older reported symptoms compatible with GAD in the previous 12 months. MDE symptoms co-occurred in 50% of these individuals. Those with GAD only reported fair/poor perceived health (29.7%), moderate to severe psychological distress (81.2%) and moderate to severe disability (28.1%) comparable to (or even slightly worse) than those with MDE only (24.7%, 78.8% and 24.8% respectively). Those with comorbid GAD and MDE demonstrated the worst health outcomes; 47.3% of them reported fair/poor perceived health, 94.0% reported moderate to severe psychological distress and 52.4% reported moderate to severe disability. Nearly 50% of those with comorbid GAD and MDE reported that their need for health care was not met or only partially met, compared to about 30% of those with GAD or MDE only. CONCLUSION: While GAD is associated with levels of distress and disability comparable to (or slightly worse) than those affected by MDE only, the health status of those with comorbid disease is significantly worse than those with GAD or MDE only. Improved diagnosis, screening for comorbidity and management are essential to minimize the impacts of this mental illness.
INTRODUCTION: Although generalized anxiety disorder (GAD) is common and disabling, there are few Canadian studies on this mental illness. We compared the characteristics, health status, health services use and health care needs of Canadians with GAD to those with depression. METHODS: Data are from the 2012 Canadian Community Health Survey-Mental Health, which surveyed a nationally representative sample of Canadians aged 15 years and older (n = 23 709; response rate of 68.9%). The respondents we studied had selfreported symptoms compatible with GAD and/or major depressive episode (MDE) in the preceding 12 months (n = 1598). Estimates were weighted to represent the Canadian household population. We performed descriptive and multinomial multivariate logistic regression analyses. RESULTS: In 2012, an estimated 700 000 (2.5%) Canadians aged 15 years and older reported symptoms compatible with GAD in the previous 12 months. MDE symptoms co-occurred in 50% of these individuals. Those with GAD only reported fair/poor perceived health (29.7%), moderate to severe psychological distress (81.2%) and moderate to severe disability (28.1%) comparable to (or even slightly worse) than those with MDE only (24.7%, 78.8% and 24.8% respectively). Those with comorbid GAD and MDE demonstrated the worst health outcomes; 47.3% of them reported fair/poor perceived health, 94.0% reported moderate to severe psychological distress and 52.4% reported moderate to severe disability. Nearly 50% of those with comorbid GAD and MDE reported that their need for health care was not met or only partially met, compared to about 30% of those with GAD or MDE only. CONCLUSION: While GAD is associated with levels of distress and disability comparable to (or slightly worse) than those affected by MDE only, the health status of those with comorbid disease is significantly worse than those with GAD or MDE only. Improved diagnosis, screening for comorbidity and management are essential to minimize the impacts of this mental illness.
Authors: Bridget F Grant; Deborah S Hasin; Frederick S Stinson; Deborah A Dawson; W June Ruan; Risë B Goldstein; Sharon M Smith; Tulshi D Saha; Boji Huang Journal: Psychol Med Date: 2005-10-05 Impact factor: 7.723
Authors: Johan Ormel; Maria Petukhova; Somnath Chatterji; Sergio Aguilar-Gaxiola; Jordi Alonso; Matthias C Angermeyer; Evelyn J Bromet; Huibert Burger; Koen Demyttenaere; Giovanni de Girolamo; Josep Maria Haro; Irving Hwang; Elie Karam; Norito Kawakami; Jean Pierre Lépine; María Elena Medina-Mora; José Posada-Villa; Nancy Sampson; Kate Scott; T Bedirhan Ustün; Michael Von Korff; David R Williams; Mingyuan Zhang; Ronald C Kessler Journal: Br J Psychiatry Date: 2008-05 Impact factor: 9.319
Authors: Sergio L Blay; Gerda G Fillenbaum; Marcelo F Mello; Maria I Quintana; Jair J Mari; Rodrigo A Bressan; Sergio B Andreoli Journal: J Affect Disord Date: 2018-02-17 Impact factor: 4.839
Authors: Jordan Edwards; Li Wang; Laura Duncan; Jinette Comeau; Kelly K Anderson; Katholiki Georgiades Journal: Child Adolesc Psychiatry Ment Health Date: 2022-06-21 Impact factor: 7.494
Authors: Sarah M Hutchison; Allison Watts; Anne Gadermann; Eva Oberle; Tim F Oberlander; Pascal M Lavoie; Louise C Mâsse Journal: J Affect Disord Rep Date: 2022-03-17
Authors: Mélissa Généreux; Mathieu Roy; Marc D David; Marie-Ève Carignan; Gabriel Blouin-Genest; S M Zeeshan Qadar; Olivier Champagne-Poirier Journal: Glob Health Promot Date: 2021-07-16
Authors: Vincent I O Agyapong; Marianne Hrabok; Michal Juhas; Joy Omeje; Edward Denga; Bernard Nwaka; Idowu Akinjise; Sandra E Corbett; Shahram Moosavi; Matthew Brown; Pierre Chue; Andrew J Greenshaw; Xin-Min Li Journal: Front Psychiatry Date: 2018-07-31 Impact factor: 4.157
Authors: Shahram Moosavi; Bernard Nwaka; Idowu Akinjise; Sandra E Corbett; Pierre Chue; Andrew J Greenshaw; Peter H Silverstone; Xin-Min Li; Vincent I O Agyapong Journal: Front Psychiatry Date: 2019-09-18 Impact factor: 4.157
Authors: Mélissa Généreux; Philip J Schluter; Kevin Kc Hung; Chi Shing Wong; Catherine Pui Yin Mok; Tracey O'Sullivan; Marc D David; Marie-Eve Carignan; Gabriel Blouin-Genest; Olivier Champagne-Poirier; Éric Champagne; Nathalie Burlone; Zeeshan Qadar; Teodoro Herbosa; Gleisse Ribeiro-Alves; Ronald Law; Virginia Murray; Emily Ying Yang Chan; Nathalie Pignard-Cheynel; Sébastien Salerno; Grégoire Lits; Leen d'Haenens; David De Coninck; Koenraad Matthys; Mathieu Roy Journal: Int J Environ Res Public Health Date: 2020-11-13 Impact factor: 3.390